These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28970029)

  • 1. Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life.
    Britton J; Keld R; Prasad N; Hamdy S; McLaughlin J; Ang Y
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):57-65. PubMed ID: 28970029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett's oesophagus and stage I oesophageal adenocarcinoma.
    di Pietro M; Trudgill NJ; Vasileiou M; Longcroft-Wheaton G; Phillips AW; Gossage J; Kaye PV; Foley KG; Crosby T; Nelson S; Griffiths H; Rahman M; Ritchie G; Crisp A; Deed S; Primrose JN
    Gut; 2024 May; 73(6):897-909. PubMed ID: 38553042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's oesophagus: a review of costs of the illness.
    Arguedas MR; Eloubeidi MA
    Pharmacoeconomics; 2001; 19(10):1003-11. PubMed ID: 11735670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.
    Britton J; Gadeke L; Lovat L; Hamdy S; Hawkey C; McLaughlin J; Ang Y
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):824-831. PubMed ID: 28867477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.
    Gudlaugsdottir S; van Blankenstein M; Dees J; Wilson JH
    Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):639-45. PubMed ID: 11434588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's oesophagus: diagnosis and management.
    Spechler SJ
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):857-79. PubMed ID: 11003814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
    Barritt AS; Shaheen NJ
    Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance in Barrett's oesophagus: a personal view.
    Basu KK; de Caestecker JS
    Postgrad Med J; 2002 May; 78(919):263-8. PubMed ID: 12151566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
    de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
    Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life measures in dysplastic Barrett's oesophagus are comparable to patients with non-dysplastic Barrett's oesophagus and do not improve after endoscopic therapy.
    Ratcliffe E; Britton J; Heal C; Keld R; Murgatroyd M; Willert R; McLaughlin J; Hamdy S; Ang Y
    BMJ Open Gastroenterol; 2023 Apr; 10(1):. PubMed ID: 37041020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Barrett's oesophagus--cancer risk, biology and therapeutic management.
    Fennerty MB; Sampliner RE; Garewal HS
    Aliment Pharmacol Ther; 1993 Aug; 7(4):339-45. PubMed ID: 8218749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needs.
    Britton J; Hamdy S; McLaughlin J; Horne M; Ang Y
    Health Expect; 2019 Feb; 22(1):21-33. PubMed ID: 30430714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.